Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy

Published:2010-12-28 Issue:1 Volume:22 Page:103-113
ISSN:1042-7147
Container-title:Polymers for Advanced Technologies
language:en
Short-container-title:Polym. Adv. Technol.

Author:

Polyak Dina,Ryppa Claudia,Eldar-Boock Anat,Ofek Paula,Many Ariel,Licha Kai,Kratz Felix,Satchi-Fainaro Ronit

Funder

The Israel Science Foundation

United States-Israel Binational Science Foundation

Recanati Fund for Medical Research

Israel Cancer Association

Igal Alon Foundation

Dr Mildred Scheel Stiftung der Deutschen Krebshilfe

Publisher

Wiley

Subject

Polymers and Plastics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pat.1731/fullpdf

Reference52 articles.

1. The curability of breast cancer and the treatment of advanced disease

2. Overview of Adjuvant Systemic Therapy in Early Stage Breast Cancer

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment;Journal of Peptide Science;2024-02-21

2. Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues;Pharmaceutics;2023-02-04

3. Combination Cancer Therapy Using Multifunctional Liposomes;Critical Reviews™ in Therapeutic Drug Carrier Systems;2020

4. Peptide-Based Therapeutics for Oncology;Pharmaceutical Medicine;2019-01-02

5. Polymeric nanomaterial revolution in drug delivery systems: toward patient care;Materials for Biomedical Engineering;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP